Re: Can big pharma afford Apabetalone?
in response to
by
posted on
Jun 17, 2018 09:28PM
Below is a link for those interested in company produced enterprise value projections for various points in time into the not too distant future. Go to page 29 of the slide deck. Enterprise values range from $1.7B USD to $7.9B USD.
https://www.resverlogix.com/upload/event/10/7abfd821f9e6/rvx-bio-europe-2017.pdf